Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients

Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02230-wMolecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients

https://www.nature.com/articles/s41375-024-02230-w

Source: Leukemia - March 27, 2024 Category: Hematology Authors: Shai Shimony Jacqueline S. Garcia Julia Keating Evan C. Chen Marlise R. Luskin Maximilian Stahl Donna S. Neuberg Daniel J. DeAngelo Richard M. Stone R. Coleman Lindsley Source Type: research

More News: Hematology | Leukemia